You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab8904 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
Dot Blot Dot: Use at an assay dependent dilution.
RIA RIA: Use at an assay dependent dilution.
WB WB: 1/5000.

Target

  • RelevanceThe cyclic tetradecapeptide somatostatin is widely distributed throughout the body and is an important regulator of endocrine and nervous system function. It exerts its biologic actions by binding to specific high affinity receptors on the cell surface. Somatostatin inhibits the release of somatotropin. Somatostatin has also been shown in sympathetic nerves, mucosal cells, myenteric nerves of the gastrointestinal tract, salivary glands and in some parafollicular cells of the thyroid. Somatostatin positive cells may also be present in medullary thyroid carcinomas, C cell hyperplasia, thymic and lung tumors and pulmonary small cell carcinomas.
  • Cellular localizationSecreted
  • Database links
    • Alternative names
        Growth hormone release inhibiting factor antibodySMST antibodySomatostatin 14 antibody
        Somatostatin 28 antibodySST antibody
      see all

    References for Anti-Somatostatin antibody (ab8904)

    ab8904 has not yet been referenced specifically in any publications.

    Publishing research using ab8904 ? Please let us know so that we can cite the reference in this datasheet

    Product Wall

    Submit an Abreview for ab8904

    Filter by Application

    Filter by Species

    Filter by Ratings

    Displaying 1 - 1 of 1 results for Abreviews

    10
    Votes: Highest First

    Western blot abreview for Anti-Somatostatin antibody

     Inconclusive
    Abreviews
    Application Western blot
    Sample Human Tissue lysate - whole (BRAIN)
    Loading amount 5 µg
    Specification BRAIN
    Gel Running Conditions Reduced Denaturing
    Blocking step LI-COR as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 50%
    Read More
    Username

    Verified customer

    Submitted Mar 17 2010

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"